Skip to main content
    C

    CME Group Inc (CME)

    Official site

    FINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ

    $319.37
    +1.40 (+0.44%)

    Market Cap: $113.81B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    CME Group Inc (CME) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    CME Group (CME) trades at 26.3x trailing earnings and 16.4x sales. Its P/E of 26.3x is above its 5-year median of 23.6x. Its forward P/E is 24.6x. The median P/E across 10 similar companies is 26.1x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 6.9% higher over the next year. Its free cash flow yield is 3.8%.

    MultipleValue
    P/E (trailing)26.3x
    Forward P/E24.6x
    Price to sales16.4x
    Price to book4.3x
    Price to FCF26.4x
    EV/FCF26.7x
    PEG4.4
    FCF yield3.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 0.4% above 26.2x, its P/S is 14.7% above 14.3x and its P/B is 65.4% above 2.6x.

    MultipleCurrent5-year median10-year median
    P/E26.3x23.6x26.2x
    P/S16.4x14.3x14.3x
    P/B4.3x2.9x2.6x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 21.1x in 2022 to 34.1x in 2021.

    Year endPriceP/EP/SP/B
    2025$273.0824.4x15.1x3.4x
    2024$232.2322.6x13.6x3.2x
    2023$210.6022.5x13.6x2.8x
    2022$168.1621.1x12.0x2.2x
    2021$228.4634.1x17.5x3.0x
    2020$182.0527.1x13.3x2.5x
    2019$200.7229.5x14.7x2.8x
    2018$188.1227.6x15.0x2.6x
    2017$146.0530.7x13.6x2.2x
    2016$115.3526.0x10.8x1.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CME

    What is CME's forward P/E ratio?

    CME Group has a forward P/E ratio of 24.6x.

    Is CME stock overvalued?

    GNG's valuation label for CME is Fairly valued. Its P/E of 26.3x compares with a median of 26.1x across 10 similar companies.

    What is CME's price to sales ratio?

    CME Group has a price to sales ratio of 16.4x.

    What is CME Group's average P/E ratio over 5 years?

    CME Group's median P/E over the last 5 years is 23.6x, from 60 month-end values through Oct 2026.

    What is CME's PEG ratio?

    CME Group has a PEG ratio of 4.4.